AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by AC Immune SA, a foreign private issuer based in Lausanne, Switzerland, for the month of March 2019. The report was signed on March 21, 2019, by CEO Andrea Pfeifer and CFO Joerg Hornstein. The filing serves to distribute specific corporate documents rather than providing a standalone financial statement for the period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. This document acts as a cover for exhibits containing the actual data.
Material Changes and Exhibits
The filing includes the following exhibits which contain the substantive information:
- Exhibit 99.1: Press Release dated March 21, 2019.
- Exhibit 99.2: 2018 Statutory Annual Report.
- Exhibit 99.3: 2018 Compensation Report.
Material changes, guidance, outlook, and risks are not detailed in the cover text of this Form 6-K but are expected to be contained within the attached exhibits.
Investor Verification Checklist
- Review the attached 2018 Statutory Annual Report (Exhibit 99.2) for audited financial results.
- Read the March 21, 2019 Press Release (Exhibit 99.1) for current operational updates or material events.
- Verify the 2018 Compensation Report (Exhibit 99.3) for executive remuneration details.
- Confirm that no interim financial data for Q1 2019 is present in this specific filing text.